Lupin Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Lupin Pharmaceuticals's estimated annual revenue is currently $1B per year.(i)
  • Lupin Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Lupin Pharmaceuticals has 5211 Employees.(i)
  • Lupin Pharmaceuticals grew their employee count by 5% last year.

Lupin Pharmaceuticals's People

NameTitleEmail/Phone
1
Sr VP Sales and MarketingReveal Email/Phone
2
EVP Commercial Operations, US GenericsReveal Email/Phone
3
VP Sales - U.S. GenericsReveal Email/Phone
4
VP, R&DReveal Email/Phone
5
SVP, Global Business Development & Portfolio - BiologicsReveal Email/Phone
6
VP - Marketing, Pricing & AnalyticsReveal Email/Phone
7
Associate Director, QualityReveal Email/Phone
8
Director, Corporate CounselReveal Email/Phone
9
Associate Director, Supply ChainReveal Email/Phone
10
Associate Director, Indirect Strategic SourcingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7M35-3%N/AN/A
#2
$7.2M36-5%N/AN/A
#3
$10.5M52-9%N/AN/A
#4
$344.1M17129%N/AN/A
#5
$27.5M1376%N/AN/A
#6
$107.3M5349%N/AN/A
#7
$12.9M6428%N/AN/A
#8
$31.6M1571%N/AN/A
#9
$31.4M1567%N/AN/A
#10
$11.5M5730%N/AN/A
Add Company

What Is Lupin Pharmaceuticals?

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top five pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.

keywords:N/A

N/A

Total Funding

5211

Number of Employees

$1B

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lupin Pharmaceuticals News

2022-04-19 - Clobazam Market Size 2022-2029| Key Players – Lupin ...

Lupin Pharmaceuticals; ROSEMONT Pharma; Merck KGaA; Breckenridge Pharmaceutical; Amneal; Upsher-Smith; Hikma. Clobazam Market Breakdown by Type: 10mg...

2022-04-13 - Arbor, Lupin End IP Suit Over Planned Blood Pressure Generic

"Plaintiffs Arbor Pharmaceuticals LLC and Takeda Pharmaceutical Co. Ltd., and defendants Lupin Ltd. and Lupin Pharmaceuticals Inc.,...

2022-04-13 - Oft-chided Lupin dinged by FDA at Indian pharmaceutical ...

Lupin's active pharmaceutical ingredient (API) plant in Tarapur, India, has been slapped with a Form 483, the company confirmed (PDF) in a filing.

2018-01-24 - Lupin gets shareholders nod to raise up to Rs 7,500 cr

Drug major Lupin today said it has received approval from its shareholders to raise up to Rs 7,500 crore through issue of securities. In a BSE filing, the Mumbai-based firm said shareholders have approved a proposal today “to raise funds for an amount not exceeding Rs 7,500 crore through issue ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$300M59837%N/A
#2
$75M64596%N/A
#3
$2411.9M78314%N/A
#4
$1992.3M79067%N/A
#5
$2064.4M8192N/AN/A